دورية أكاديمية
Characterization of virulence determinants and phylogenetic background of multiple and extensively drug resistant Escherichia coli isolated from different clinical sources in Egypt.
| العنوان: | Characterization of virulence determinants and phylogenetic background of multiple and extensively drug resistant Escherichia coli isolated from different clinical sources in Egypt. |
|---|---|
| المؤلفون: | El-Baz R; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt., Said HS; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. hebashehta@mans.edu.eg., Abdelmegeed ES; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt., Barwa R; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. rasha@mans.edu.eg. |
| المصدر: | Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2022 Feb; Vol. 106 (3), pp. 1279-1298. Date of Electronic Publication: 2022 Jan 20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer International Country of Publication: Germany NLM ID: 8406612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0614 (Electronic) Linking ISSN: 01757598 NLM ISO Abbreviation: Appl Microbiol Biotechnol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Berlin ; New York : Springer International, c1984- |
| مواضيع طبية MeSH: | Escherichia coli Infections*/epidemiology , Pharmaceutical Preparations*, Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Diarrhea ; Egypt/epidemiology ; Escherichia coli/genetics ; Humans ; Phylogeny ; Travel ; Virulence ; Virulence Factors/genetics |
| مستخلص: | Escherichia coli is a multifaceted microbe since some are commensals, normally inhabiting the gut of both humans and animals while others are pathogenic responsible for a wide range of intestinal and extra-intestinal infections. It is one of the leading causes of septicemia, neonatal meningitis, urinary tract infections (UTIs), cystitis, pyelonephritis, and traveler's diarrhea. The present study aims to survey the distribution and unravel the association of phylotypes, virulence determinants, and antimicrobial resistance of E. coli isolated from different clinical sources in Mansoura hospitals, Egypt. One hundred and fifty E. coli isolates were collected from different clinical sources. Antimicrobial resistance profile, virulence determinants, and virulence encoding genes were detected. Moreover, phylogenetic and molecular typing using ERIC-PCR analysis was performed. Our results have revealed that phylogroup B2 (26.67%) with the greatest content in virulence traits was the most prevalent phylogenetic group. Different virulence profiles and varying incidence of virulence determinants were detected among tested isolates. High rates of resistance to different categories of antimicrobial agents, dramatic increase of MDR (92.67%), and emergence of XDR (4%) were detected. ERIC-PCR analysis revealed great diversity among tested isolates. There was no clustering of isolates according to resistance, virulence patterns, or phylotypes. Our research has demonstrated significant phylogenetic diversity of E. coli isolated from different clinical sources in Mansoura hospitals, Dakahlia governorate, Egypt. E. coli isolates are equipped with various virulence factors which contribute to their pathogenesis in human. The elevated rates of antimicrobial resistance and emergence of MDR and XDR mirror the trend detected globally in recent years. KEY POINTS: • Clinical E. coli isolates exhibited substantial molecular and phylogenetic diversity. • Elevated rates of antimicrobial resistance and emergence of XDR in pathogenic E. coli. • B2 Phylogroup with the highest VS was the most prevalent among pathogenic E. coli. (© 2022. The Author(s).) |
| References: | Abad ED, Khameneh A, Vahedi L (2019) Identification phenotypic and genotypic characterization of biofilm formation in Escherichia coli isolated from urinary tract infections and their antibiotics resistance. BMC Res Notes 12(1):1–7. https://doi.org/10.1186/s13104-019-4825-8. (PMID: 10.1186/s13104-019-4825-8) Abd El-Baky RM, Ibrahim RA, Mohamed DS, Ahmed EF, Hashem ZS (2020) Prevalence of virulence genes and their association with antimicrobial resistance among pathogenic E. coli isolated from Egyptian patients with different clinical infections. Infect Drug Resist 13:1221. https://doi.org/10.2147/IDR.S241073. (PMID: 10.2147/IDR.S241073324255607196243) Abdelmegeed ES, Barwa R, Abd El Galil KH (2015) Comparative study on prevalence and association of some virulence factors with extended spectrum beta-lactamases and AmpC producing Escherichia coli. Afr J Microbiol Res 9(17):1165–1174. https://doi.org/10.5897/AJMR2015.7463. (PMID: 10.5897/AJMR2015.7463) Abdelraouf K, Chavda KD, Satlin MJ, Jenkins SG, Kreiswirth BN, Nicolau DP (2020) Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: resistance mechanisms and in vitro-in vivo discordance. Int J Antimicrob Agents 55(3):105885. https://doi.org/10.1016/j.ijantimicag.2020.105885. (PMID: 10.1016/j.ijantimicag.2020.10588531923568) Aladarose BE, Said HS, Abdelmegeed ES (2019) Incidence of virulence determinants among enterococcal clinical isolates in Egypt and its association with biofilm formation. Microb Drug Resist (larchmont, NY) 25(6):880–889. https://doi.org/10.1089/mdr.2018.0320. (PMID: 10.1089/mdr.2018.0320) Ananias M, Yano T (2008) Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41(10):877–883. https://doi.org/10.1590/S0100-879X2008001000008. (PMID: 10.1590/S0100-879X200800100000819030710) Ansari S, Nepal HP, Gautam R, Shrestha S, Neopane P, Gurung G, Chapagain ML (2015) Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. Antimicrob Resist Infect Control 4:15. https://doi.org/10.1186/s13756-015-0059-2. (PMID: 10.1186/s13756-015-0059-2259379234416386) Aranda KR, Fabbricotti SH, Fagundes-Neto U, Scaletsky IC (2007) Single multiplex assay to identify simultaneously enteropathogenic, enteroaggregative, enterotoxigenic, enteroinvasive and Shiga toxin-producing Escherichia coli strains in Brazilian children. FEMS Microbiol Lett 267(2):145–150. https://doi.org/10.1111/j.1574-6968.2006.00580.x. (PMID: 10.1111/j.1574-6968.2006.00580.x17328113) Beceiro A, Tomás M, Bou G (2013) Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev 26(2):185–230. https://doi.org/10.1128/CMR.00059-12. (PMID: 10.1128/CMR.00059-12235544143623377) Blanco M, Blanco J, Alonso M, Mora A, Balsalobre C, Munoa F, Juárez A, Blanco J (1997) Detection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: relationship with expression of adhesins and production of toxins. Res Microbiol 148(9):745–755. https://doi.org/10.1016/S0923-2508(97)82450-3. (PMID: 10.1016/S0923-2508(97)82450-39765858) Blount ZD (2015) The natural history of model organisms: the unexhausted potential of E. coli. ELife 4:e05826. https://doi.org/10.7554/eLife.05826. (PMID: 10.7554/eLife.058264373459) Bozcal E, Eldem V, Aydemir S, Skurnik M (2018) The relationship between phylogenetic classification, virulence and antibiotic resistance of extraintestinal pathogenic Escherichia coli in İzmir province. Turkey Peerj 6:e5470. https://doi.org/10.7717/peerj.5470. (PMID: 10.7717/peerj.547030155366) Cepas V, López Y, Muñoz E, Rolo D, Ardanuy C, Martí S, Xercavins M, Horcajada JP, Bosch J, Soto SM (2019) Relationship between biofilm formation and antimicrobial resistance in Gram-negative bacteria. Microb Drug Resist (larchmont, NY) 25(1):72–79. https://doi.org/10.1089/mdr.2018.0027. (PMID: 10.1089/mdr.2018.0027) Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558. https://doi.org/10.1128/AEM.66.10.4555-4558.2000. (PMID: 10.1128/AEM.66.10.4555-4558.20001101091692342) Clermont O, Christenson JK, Denamur E, Gordon DM (2013) The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 5(1):58–65. https://doi.org/10.1111/1758-2229.12019. (PMID: 10.1111/1758-2229.1201923757131) CLSI (2018) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI Document M100-S27. 940 Wayne, PA, U.S.A. 2018. 36. Colle JGMRS, Watt B (1996) Tests for identification of bacteria. In: Colle JGFAG, Marimon BP, Simmon A (eds) Mackie & MacCartney practical medical microbiology, 14th edn. Churchill Livingstone, Edinburgh, pp 151–179. Čurová K, Slebodníková R, Kmeťová M, Hrabovský V, Maruniak M, Liptáková E, Siegfried L (2020) Virulence, phylogenetic background and antimicrobial resistance in Escherichia coli associated with extraintestinal infections. J Infect Public Heal 13(10):1537–1543. https://doi.org/10.1016/j.jiph.2020.06.032. (PMID: 10.1016/j.jiph.2020.06.032) da Cruz Campos AC, Couto N, da Silva Andrade NL, Friedrich AW, de Paula Rosa AC, Damasco PV, Chlebowicz-Fliss MA, Rossen JW, Group SW (2020) Virulence and resistance properties of E. coli isolated from urine samples of hospitalized patients in Rio de Janeiro, Brazil–the role of mobile genetic elements. Int J Med Microbiol 310(8):151453. https://doi.org/10.1016/j.ijmm.2020.151453. (PMID: 10.1016/j.ijmm.2020.15145333045580) Da Silva GJ, Mendonça N (2012) Association between antimicrobial resistance and virulence in Escherichia coli. Virulence 3(1):18–28. https://doi.org/10.4161/viru.3.1.18382. (PMID: 10.4161/viru.3.1.1838222286707) Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W (2020) Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa. Ethiopia. BMC Infect Dis 20(1):108. https://doi.org/10.1186/s12879-020-4844-z. (PMID: 10.1186/s12879-020-4844-z32033541) Daga AP, Koga VL, de Matos CM, Perugini MRE, Pelisson M, Kobayashi RKT, Vespero EC (2019) Escherichia coli bloodstream infections in patients at a university hospital: virulence factors and clinical characteristics. Front Cellular Infect Microbiol 9:191. https://doi.org/10.3389/fcimb.2019.00191. (PMID: 10.3389/fcimb.2019.00191) Dehkordi FS, Tavakoli-Far B, Jafariaskari S, Momtaz H, Esmaeilzadeh S, Ranjbar R, Rabiei M (2020) Uropathogenic Escherichia coli in the high vaginal swab samples of fertile and infertile women: virulence factors, O-serogroups, and phenotyping and genotyping characterization of antibiotic resistance. New Microbe and New Infect 38:100824. https://doi.org/10.1016/j.nmni.2020.100824. (PMID: 10.1016/j.nmni.2020.100824) Duan Y, Gao H, Zheng L, Liu S, Cao Y, Zhu S, Wu Z, Ren H, Mao D, Luo Y (2020) Antibiotic resistance and virulence of extraintestinal pathogenic Escherichia coli (ExPEC) vary according to molecular types. Front Microbiol 11:598305. https://doi.org/10.3389/fmicb.2020.598305. (PMID: 10.3389/fmicb.2020.598305333294877732638) Dubreuil JD (2019) EAST1 toxin: an enigmatic molecule associated with sporadic episodes of diarrhea in humans and animals. J Microbiol 57(7):541–549. https://doi.org/10.1007/s12275-019-8651-4. (PMID: 10.1007/s12275-019-8651-431016564) El-Shaer S, Abdel-Rhman SH, Barwa R, Hassan R (2018) Virulence Characteristics, serotyping and phylogenetic typing of clinical and environmental Escherichia coli isolates. Jundishapur J Microbiol 11(12):e82835. https://doi.org/10.5812/jjm.82835. (PMID: 10.5812/jjm.82835) Escobar-Páramo P, Grenet K, Le Menac’h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A (2004) Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol 70(9):5698–5700. https://doi.org/10.1128/AEM.70.9.5698-5700.2004. (PMID: 10.1128/AEM.70.9.5698-5700.200415345464520916) Fabbri A, Travaglione S, Fiorentini C (2010) Escherichia coli cytotoxic necrotizing factor 1 (CNF1): toxin biology, in vivo applications and therapeutic potential. Toxins 2(2):283–296. https://doi.org/10.3390/toxins2020282. (PMID: 10.3390/toxins2020282220695843202811) Flament-Simon SC, Nicolas-Chanoine MH, García V, Duprilot M, Mayer N, Alonso MP, García-Meniño I, Blanco JE, Blanco M, Blanco J (2020) Clonal structure, virulence factor-encoding genes and antibiotic resistance of Escherichia coli, causing urinary tract infections and other extraintestinal infections in humans in Spain and France during 2016. Antibiotics 9(4):161. https://doi.org/10.3390/antibiotics9040161. (PMID: 10.3390/antibiotics90401617235800) Heras J, Dominguez C, Mata E, Pascual V, Lozano C, Torres C, Zarazaga M (2015) GelJ–a tool for analyzing DNA fingerprint gel images. BMC Bioinform 16:270. https://doi.org/10.1186/s12859-015-0703-0. (PMID: 10.1186/s12859-015-0703-0) Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A (2015) Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. BioMed Res Int 2015:846219. https://doi.org/10.1155/2015/846219. (PMID: 10.1155/2015/846219256921474322292) Johnson JR (1998) papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise. Infect Immun 66(9):4568–4571. https://doi.org/10.1128/IAI.66.9.4568-4571.1998. (PMID: 10.1128/IAI.66.9.4568-4571.19989712823108561) Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG (2016) Escherichia coli sequence type 131 H30 is the main driver of emerging extended-spectrum-β-lactamase-producing E. coli at a tertiary care center. Msphere 1(6):e00314-16. https://doi.org/10.1128/mSphere.00314-16. (PMID: 10.1128/mSphere.00314-16279048845120173) Johnson JR, Porter S, Thuras P, Castanheira M, 2017 The pandemic H30 subclone of sequence type 131 (ST131) as the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011–2012). In: Open forum infectious diseases,. vol 4. Oxford University Press. Johnson JR, Russo TA (2002) Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis 186(6):859–864. https://doi.org/10.1086/342490. (PMID: 10.1086/34249012198625) Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181(1):261–272. https://doi.org/10.1086/315217. (PMID: 10.1086/31521710608775) Kaper JB (2005) Pathogenic Escherichia coli. Int J Med Microbiol 295(6–7):355–356. https://doi.org/10.1016/j.ijmm.2005.06.008. (PMID: 10.1016/j.ijmm.2005.06.00816238012) Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2(2):123–140. https://doi.org/10.1038/nrmicro818. (PMID: 10.1038/nrmicro81815040260) Karam MRA, Habibi M, Bouzari S (2018) Relationships between virulence factors and antimicrobial resistance among Escherichia coli isolated from urinary tract infections and commensal isolates in Tehran, Iran. Osong Public health Res Perspect 9(5):217. https://doi.org/10.24171/j.phrp.2018.9.5.02. (PMID: 10.24171/j.phrp.2018.9.5.0230402376) Khairy RM, Fathy ZA, Mahrous DM, Mohamed ES, Abdelrahim SS (2020) Prevalence, phylogeny, and antimicrobial resistance of Escherichia coli pathotypes isolated from children less than 5 years old with community acquired-diarrhea in Upper Egypt. BMC Infect Dis 20(1):1–9. https://doi.org/10.1186/s12879-020-05664-6. (PMID: 10.1186/s12879-020-05664-6) Koga VL, Tomazetto G, Cyoia PS, Neves MS, Vidotto MC, Nakazato G, Kobayashi RK (2014) Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. BioMed Res Int 2014:465054. https://doi.org/10.1155/2014/465054. (PMID: 10.1155/2014/465054248222114009324) Kot B, Wicha J, Gruzewska A, Piechota M, Wolska K, Obrebska M (2016) Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci 46(6):1908–1914. https://doi.org/10.3906/sag-1508-105. (PMID: 10.3906/sag-1508-10528081347) Li G, Tivendale KA, Liu P, Feng Y, Wannemuehler Y, Cai W, Mangiamele P, Johnson TJ, Constantinidou C, Penn CW (2011) Transcriptome analysis of avian pathogenic Escherichia coli O1 in chicken serum reveals adaptive responses to systemic infection. Infect Immun 79(5):1951–1960. https://doi.org/10.1128/IAI.01230-10. (PMID: 10.1128/IAI.01230-10213577213088125) Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x. (PMID: 10.1111/j.1469-0691.2011.03570.x) Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, Jahanabadi Z (2018) Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients. BMC Infect Dis 18(1):572. https://doi.org/10.1186/s12879-018-3467-0. (PMID: 10.1186/s12879-018-3467-0304421016238375) Maluta RP, Leite JL, Rojas TCG, Scaletsky ICA, Guastalli EAL, Ramos MdC, Dias da Silveira W (2017) Variants of astA gene among extra-intestinal Escherichia coli of human and avian origin. FEMS Microbiol Lett 364:6. https://doi.org/10.1093/femsle/fnw285. (PMID: 10.1093/femsle/fnw285) Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E (2006) Probiotic potential of Lactobacillus strains isolated from dairy products. Int Dairy J 16(3):189–199. https://doi.org/10.1016/j.idairyj.2005.02.009. (PMID: 10.1016/j.idairyj.2005.02.009) Masoud SM, El-Baky A, Mahmoud R, Aly SA, Ibrahem RA (2021) Co-existence of certain ESBLs, MBLs and plasmid mediated quinolone resistance genes among MDR E. coli isolated from different clinical specimens in Egypt. Antibiotics 10(7):835. https://doi.org/10.3390/antibiotics10070835. (PMID: 10.3390/antibiotics10070835343567568300665) Mellata M, Dho-Moulin M, Dozois CM, Curtiss R III, Brown PK, Arné P, Brée A, Desautels C, Fairbrother JM (2003) Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. Infect Immun 71(1):536–540. https://doi.org/10.1128/IAI.71.1.536-540.2003. (PMID: 10.1128/IAI.71.1.536-540.200312496207143143) Micenková L, Beňová A, Frankovičová L, Bosák J, Vrba M, Ševčíková A, Kmeťová M, Šmajs D (2017) Human Escherichia coli isolates from hemocultures: septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions. Int J Med Microbiol 307(3):182–189. https://doi.org/10.1016/j.ijmm.2017.02.003. (PMID: 10.1016/j.ijmm.2017.02.00328268063) Monroy-Pérez E, Cerón AB, García Cortés LR, Alonso NN, Domínguez-Trejo P, Hernández-Jaimes T, Bustos-Martínez J, Hamdan-Partida A, Rojas Jiménez EA, Vaca S, Vaca-Paniagua F, Paniagua-Contreras GL (2020) Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenic E. coli in Mexico. PloS one 15(6):e0234730. https://doi.org/10.1371/journal.pone.0234730. (PMID: 10.1371/journal.pone.0234730325693087307731) Moon JY, Park JH, Kim YB (2005) Molecular epidemiological characteristics of virulence factors on enteroaggregative E. coli. FEMS Microbiol Lett 253(2):215–220. https://doi.org/10.1016/j.femsle.2005.09.038. (PMID: 10.1016/j.femsle.2005.09.03816257141) Morgan RN, Saleh SE, Farrag HA, Aboulwafa MM (2019) Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses. Gut Pathog 11(1):1–18. https://doi.org/10.1186/s13099-019-0304-y. (PMID: 10.1186/s13099-019-0304-y) Mosquito S, Pons MJ, Riveros M, Ruiz J, Ochoa TJ (2015) Diarrheagenic Escherichia coli phylogroups are associated with antibiotic resistance and duration of diarrheal episode. Sci World J 2015:610403. https://doi.org/10.1155/2015/610403. (PMID: 10.1155/2015/610403) Murinda SE, Nguyen LT, Ivey SJ, Almeida RA, Oliver SP (2002) Novel single-tube agar-based test system for motility enhancement and immunocapture of Escherichia coli O157:H7 by H7 flagellar antigen-specific antibodies. J Clin Microbiol 40(12):4685–4690. https://doi.org/10.1128/jcm.40.12.4685-4690.2002. (PMID: 10.1128/jcm.40.12.4685-4690.200212454173154605) Naves P, del Prado G, Huelves L, Gracia M, Ruiz V, Blanco J, Dahbi G, Blanco M, del Carmen PM, Soriano F (2008) Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb Pathog 45(2):86–91. https://doi.org/10.1016/j.micpath.2008.03.003. (PMID: 10.1016/j.micpath.2008.03.00318486439) Nichols KB, Totsika M, Moriel DG, Lo AW, Yang J, Wurpel DJ, Rossiter AE, Strugnell RA, Henderson IR, Ulett GC (2016) Molecular characterization of the vacuolating autotransporter toxin in uropathogenic Escherichia coli. J Bacteriol 198(10):1487–1498. https://doi.org/10.1128/JB.00791-15. (PMID: 10.1128/JB.00791-15268581034859599) Noie Oskouie A, Hasani A, Ahangarzadeh Rezaee M, Soroush Bar Haghi MH, Hasani A, Soltani E (2019) A relationship between O-serotype, antibiotic susceptibility and biofilm formation in Uropathogenic Escherichia coli. Microb Drug Resist 25(6):951–958. https://doi.org/10.1089/mdr.2018.0330. (PMID: 10.1089/mdr.2018.033030817229) Nojoomi F, Ghasemian A (2019) The relation of phylogroups, serogroups, virulence factors and resistance pattern of Escherichia coli isolated from children with septicemia. New Microbes New Infect 29:100517. https://doi.org/10.1016/j.nmni.2019.100517. (PMID: 10.1016/j.nmni.2019.100517310806216501060) Ochoa SA, Cruz-Córdova A, Luna-Pineda VM, Reyes-Grajeda JP, Cázares-Domínguez V, Escalona G, Sepúlveda-González ME, López-Montiel F, Arellano-Galindo J, López-Martínez B, Parra-Ortega I, Giono-Cerezo S, Hernández-Castro R, de la Rosa-Zamboni D, Xicohtencatl-Cortes J (2016) Multidrug- and extensively drug-resistant uropathogenic Escherichia coli clinical strains: phylogenetic groups widely associated with integrons maintain high genetic diversity. Front Microbiol 7:2042. https://doi.org/10.3389/fmicb.2016.02042. (PMID: 10.3389/fmicb.2016.02042280663645174082) Ori EL, Takagi EH, Andrade TS, Miguel BT, Cergole-Novella MC, Guth BEC, Hernandes RT, Dias RCB, Pinheiro SRS, Camargo CH, Romero EC, Dos Santos LF (2018) Diarrhoeagenic Escherichia coli and Escherichia albertii in Brazil: pathotypes and serotypes over a 6-year period of surveillance. Epidemiol Infect 147:1–9. https://doi.org/10.1017/s0950268818002595. (PMID: 10.1017/s0950268818002595) Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, Sayami S, Khanal PR (2017) High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control 6:9. https://doi.org/10.1186/s13756-016-0168-6. (PMID: 10.1186/s13756-016-0168-6280969775225645) Paton AW, Paton JC (1998) Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx Petty NK, Zakour NLB, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan M-D, Moriel DG, Peters KM, Davies M (2014) Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA 111(15):5694–5699. https://doi.org/10.1073/pnas.1322678111. (PMID: 10.1073/pnas.1322678111247068083992628) Ponnusamy P, Natarajan V, Sevanan M (2012) In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac J Trop Med 5(3):210–213. https://doi.org/10.1016/S1995-7645(12)60026-1. (PMID: 10.1016/S1995-7645(12)60026-122305786) Ramirez Castillo FY, Avelar González FJ, Garneau P, Marquez Diaz F, Guerrero Barrera AL, Harel J (2013) Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes. Mexico Front Microbiol 4:147. https://doi.org/10.3389/fmicb.2013.00147. (PMID: 10.3389/fmicb.2013.0014723785356) Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL (2018) An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob 17(1):34. https://doi.org/10.1186/s12941-018-0286-5. (PMID: 10.1186/s12941-018-0286-5300416526057003) Ramos-Vivas J, Chapartegui-González I, Fernández-Martínez M, González-Rico C, Fortún J, Escudero R, Marco F, Linares L, Montejo M, Aranzamendi M, Muñoz P, Valerio M, Aguado JM, Resino E, Ahufinger IG, Vega AP, Martínez-Martínez L, Fariñas MC (2019) Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients. Sci Rep 9(1):8928. https://doi.org/10.1038/s41598-019-45060-y. (PMID: 10.1038/s41598-019-45060-y312220896586660) Rehman MU, Zhang H, Iqbal MK, Mehmood K, Huang S, Nabi F, Luo H, Lan Y, Li J (2017) Antibiotic resistance, serogroups, virulence genes, and phylogenetic groups of Escherichia coli isolated from yaks with diarrhea in Qinghai Plateau. China Gut Pathog 9:24. https://doi.org/10.1186/s13099-017-0174-0. (PMID: 10.1186/s13099-017-0174-028546830) Rojas-Lopez M, Monterio R, Pizza M, Desvaux M, Rosini R (2018) Intestinal pathogenic Escherichia coli: insights for vaccine development. Front Microbiol 9:440. https://doi.org/10.3389/fmicb.2018.00440. (PMID: 10.3389/fmicb.2018.00440296159895869917) Rossignol G, Merieau A, Guerillon J, Veron W, Lesouhaitier O, Feuilloley MG, Orange N (2008) Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol 8(1):1–14. https://doi.org/10.1186/1471-2180-8-189. (PMID: 10.1186/1471-2180-8-189) Said HS, Benmahmod AB, Ibrahim RH (2018) Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World J Microbiol Biotechnol 34(12):1–9. https://doi.org/10.1007/s11274-018-2571-z. (PMID: 10.1007/s11274-018-2571-z) Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4(4):406–425. https://doi.org/10.1093/oxfordjournals.molbev.a040454. (PMID: 10.1093/oxfordjournals.molbev.a0404543447015) Sallam KI, Mohammed MA, Ahdy AM, Tamura T (2013) Prevalence, genetic characterization and virulence genes of sorbitol-fermenting Escherichia coli O157: H-and E. coli O157: H7 isolated from retail beef. Int J Food Microbiol 165(3):295–301. https://doi.org/10.1016/j.ijfoodmicro.2013.05.024. (PMID: 10.1016/j.ijfoodmicro.2013.05.02423803571) Samet M, Ghaemi E, Jahanpur S, Jamalli A (2013) Evaluation of biofilm-forming capabilities of urinary Escherichia coli isolates in microtiter plate using two different culture media. Int J Mol Clin Microbiol 3(1):244–247. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, Choroszy-Krol I (2019) Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog 11(1):1–16. https://doi.org/10.1186/s13099-019-0290-0. (PMID: 10.1186/s13099-019-0290-0) Schönborn S, Wente N, Paduch J-H, Krömker V (2017) In vitro ability of mastitis causing pathogens to form biofilms. J Dairy Res 84(2):198. https://doi.org/10.1017/S0022029917000218. (PMID: 10.1017/S002202991700021828524019) Sheikh AF, Goodarzi H, Yadyad MJ, Aslani S, Amin M, Jomehzadeh N, Ranjbar R, Moradzadeh M, Azarpira S, Akhond MR (2019) Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Infect Drug Resist 12:2039. https://doi.org/10.2147/IDR.S199764. (PMID: 10.2147/IDR.S199764) Singh S, Singh SK, Chowdhury I, Singh R (2017) Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J 11:53. https://doi.org/10.2174/1874285801711010053. (PMID: 10.2174/1874285801711010053285534165427689) Sobhy NM, Yousef SGA, Aboubakr HA, Nisar M, Nagaraja KV, Mor SK, Valeris-Chacin RJ, Goyal SM (2020) Virulence factors and antibiograms of Escherichia coli isolated from diarrheic calves of Egyptian cattle and water buffaloes. PLoS ONE 15(5):e0232890. https://doi.org/10.1371/journal.pone.0232890. (PMID: 10.1371/journal.pone.0232890323922377213691) Soto S, Smithson A, Martinez J, Horcajada J, Mensa J, Vila J (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177(1):365–368. https://doi.org/10.1016/j.juro.2006.08.081. (PMID: 10.1016/j.juro.2006.08.08117162092) Spurbeck RR, Dinh PC, Walk ST, Stapleton AE, Hooton TM, Nolan LK, Kim KS, Johnson JR, Mobley HL (2012) Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun 80(12):4115–4122. https://doi.org/10.1128/IAI.00752-12. (PMID: 10.1128/IAI.00752-12229660463497434) Subashchandrabose S, Mobley HL (2015) Back to the metal age: battle for metals at the host–pathogen interface during urinary tract infection. Metallomics 7(6):935–942. https://doi.org/10.1039/c4mt00329b. (PMID: 10.1039/c4mt00329b256778274634365) Taghadosi R, Shakibaie MR, Masoumi S (2015) Biochemical detection of N-Acyl homoserine lactone from biofilm-forming uropathogenic Escherichia coli isolated from urinary tract infection samples. Rep Biochem Mol Biol 3(2):56. (PMID: 269897384757042) Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P (2010) Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect Immun 78(5):1824–1831. https://doi.org/10.1128/IAI.01397-09. (PMID: 10.1128/IAI.01397-09202314042863518) Um MM, Brugère H, Kérourédan M, Oswald E, Bibbal D (2018) Antimicrobial resistance profiles of enterohemorrhagic and enteropathogenic Escherichia coli of serotypes O157:H7, O26:H11, O103:H2, O111:H8, O145:H28 compared to Escherichia coli isolated from the same adult cattle. Microb Drug Resist (larchmont, NY) 24(6):852–859. https://doi.org/10.1089/mdr.2017.0106. (PMID: 10.1089/mdr.2017.0106) Van Houdt R, Michiels CW (2005) Role of bacterial cell surface structures in Escherichia coli biofilm formation. Res Microbiol 156(5–6):626–633. https://doi.org/10.1016/j.resmic.2005.02.005. (PMID: 10.1016/j.resmic.2005.02.00515950122) Vandekerchove D, Vandemaele F, Adriaensen C, Zaleska M, Hernalsteens J-P, De Baets L, Butaye P, Van Immerseel F, Wattiau P, Laevens H (2005) Virulence-associated traits in avian Escherichia coli: comparison between isolates from colibacillosis-affected and clinically healthy layer flocks. Vet Microbiol 108(1–2):75–87. https://doi.org/10.1016/j.vetmic.2005.02.009. (PMID: 10.1016/j.vetmic.2005.02.00915917135) Versalovic J, Koeuth T, Lupski R (1991) Distribution of repetitive DNA sequences in eubacteria and application to finerpriting of bacterial enomes. Nucleic Acids Res 19(24):6823–6831. https://doi.org/10.1093/nar/19.24.6823. (PMID: 10.1093/nar/19.24.68231762913329316) Vranic SM, Uzunovic A (2016) Antimicrobial resistance of Escherichia coli strains isolated from urine at outpatient population: a single laboratory experience. Mater Sociomed 28(2):121–124. https://doi.org/10.5455/msm.2016.28.121-124. (PMID: 10.5455/msm.2016.28.121-124271479184851537) Wang H, Zhong Z, Luo Y, Cox E, Devriendt B (2019) heat-stable enterotoxins of enterotoxigenic Escherichia coli and their impact on host immunity. Toxins 11(1):24. https://doi.org/10.3390/toxins11010024. (PMID: 10.3390/toxins110100246356903) Wang Q, Zhang P, Zhao D, Jiang Y, Zhao F, Wang Y, Li X, Du X, Yu Y (2018) Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment. Infect Drug Resist 11:2241–2248. https://doi.org/10.2147/idr.S179618. (PMID: 10.2147/idr.S179618305190626239116) Wijetunge D, Gongati S, DebRoy C, Kim K, Couraud P, Romero I, Weksler B, Kariyawasam S (2015) Characterizing the pathotype of neonatal meningitis causing Escherichia coli (NMEC). BMC Microbiol 15(1):1–15. https://doi.org/10.1186/s12866-015-0547-9. (PMID: 10.1186/s12866-015-0547-9) Wilson BR, Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y (2016) Siderophores in iron metabolism: from mechanism to therapy potential. Trends Mol Med 22(12):1077–1090. https://doi.org/10.1016/j.molmed.2016.10.005. (PMID: 10.1016/j.molmed.2016.10.005278256685135587) Woodward M, Carroll P, Wray C (1992) Detection of entero-and verocyto-toxin genes in Escherichia coli from diarrhoeal disease in animals using the polymerase chain reaction. Vet Microbiol 31(2–3):251–261. https://doi.org/10.1016/0378-1135(92)90083-6. (PMID: 10.1016/0378-1135(92)90083-61626374) Yılmaz EŞ, Aslantaş Ö (2020) Phylogenetic group/subgroups distributions, virulence factors, and antimicrobial susceptibility of Escherichia coli strains from urinary tract infections in Hatay. Rev Soc Bras Med Trop 53:e20190429. https://doi.org/10.1590/0037-8682-0429-2019. (PMID: 10.1590/0037-8682-0429-2019320492047083342) Zamani H, Salehzadeh A (2018) Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes. Turk J Med Sci 48(1):162–167. https://doi.org/10.3906/sag-1707-3. (PMID: 10.3906/sag-1707-329479978) Zhao F, Yang H, Bi D, Khaledi A, Qiao M (2020) A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections. Microb Pathog 144(2020):104196. https://doi.org/10.1016/j.micpath.2020.104196. (PMID: 10.1016/j.micpath.2020.1041963228325832283258) |
| فهرسة مساهمة: | Keywords: Biofilm formation; Clermont’s phylogenetic typing; ERIC-PCR genotyping; Escherichia coli; MDR; Resistance score; Virulence determinants; Virulence profile; Virulence score; XDR |
| المشرفين على المادة: | 0 (Anti-Bacterial Agents) 0 (Pharmaceutical Preparations) 0 (Virulence Factors) |
| تواريخ الأحداث: | Date Created: 20220120 Date Completed: 20220208 Latest Revision: 20220312 |
| رمز التحديث: | 20240829 |
| مُعرف محوري في PubMed: | PMC8816750 |
| DOI: | 10.1007/s00253-021-11740-x |
| PMID: | 35050388 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-0614 |
|---|---|
| DOI: | 10.1007/s00253-021-11740-x |